Bachem 

Bachem Holding AG, a technology-based biochemicals company, provides services to the pharmaceutical and biotechnology industries primarily in Switzerland, the United States, Germany, Ireland, the United Kingdom, Austria, Japan, and internationally. It develops and manufactures peptide and oligonucleotides as active pharmaceutical ingredients (APIs), as well as biochemicals for research purposes. The company offers research products, which include peptides, amino acid derivatives, and biochemicals for peptide research; and custom synthesis services. It also provides API products comprising generic APIs used in the fields of cancer, diabetes, obesity, fertility, and others; and peptides for new chemical entities. In addition, the company offers oligonucleotide-based APIs, as well as customer support services. Bachem Holding AG was founded in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG is a subsidiary of Ingro Finanz AG.